<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1801233113
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Cefodox
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFPODOXIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        98.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PHARMA INTERNATIONAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD13
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefodox<sup>&reg; </sup>is an antibiotic. It belongs to a group of antibiotics that are called cephalosporins. These types of antibiotics are similar to penicillin.</p><p><strong>Cefodox<sup>&reg;</sup></strong><sup> </sup>kills bacteria and it can be used against various sorts of infections.</p><p>Like all antibiotics, <strong>Cefodox<sup>&reg; </sup></strong>is only effective against some types of bacteria. So, it is only suitable for treating some types of infection.</p><p>Cefodox<sup>&reg; </sup>can be used to treat:</p><p>&bull; Sinus infections.</p><p>&bull; Throat infections.</p><p>&bull; Chest infections such as bronchitis and some types of pneumonia.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take </strong><strong>Cefodox<sup>&reg;</sup>:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to cefpodoxime proxetil or to any of the other ingredients of <strong>Cefodox<sup>&reg;</sup></strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to any other cephalosporin type of antibiotic.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had a severe allergic reaction to any sort of penicillin antibiotic.</p><p>Not all people who are allergic to penicillins are also allergic to cephalosporins.</p><p>However, you should not take this medicine if you have ever had a severe allergic reaction to any penicillin. This is because you might also be allergic to this medicine.</p><p>If you are not sure about anything, ask your doctor or pharmacist.</p><p><strong>Take special care with </strong><strong>Cefodox<sup>&reg;</sup></strong><strong>: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had an allergic reaction to any antibiotic, tell your doctor or pharmacist before you take this medicine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever been told that your kidneys do not work very well. Also, if you are having any sort of treatment (like dialysis) for kidney failure. You may take <strong>Cefodox<sup>&reg;</sup></strong> but you may need a lower dose.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had inflammation of your bowel, called colitis or any other severe disease affecting your gut.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This medicine can alter the results of some blood tests (such as cross-matching blood and the Coombs&#39; test). It is important to tell the doctor that you are taking this medicine if you have to have any of these tests.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This medicine can also alter the results of urine tests for sugar (such as Benedict&#39;s or Fehling&#39;s tests). If you have diabetes and routinely test your urine, tell your doctor. This is because other tests may have to be used to monitor your diabetes while you are having this medicine.</p><p><strong>Taking other medicines </strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>This medicine can be affected by other medicines that are removed by the kidneys. This is especially if these other medicines also affect how well kidneys work. There are many medicines that can do this, so should check with your doctor or pharmacist before taking this medicine.</p><p><strong>In particular, tell your doctor or pharmacist if you are taking: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antibiotics called aminoglycosides (such as gentamicin).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water tablets or injections (diuretics) such as furosemide. It might be necessary to check your kidneys often during treatment. This can be done with blood and urine tests.</p><p>Do not take <strong>Cefodox<sup>&reg; </sup></strong>at the same time as medicines which act against stomach acid. These include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antacids.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines like ranitidine, famotidine or cimetidine (called H2-receptor antagonists).</p><p>Leave two or three hours after taking this medicine before taking any of these other medicines.</p><p><strong>Taking </strong><strong>Cefodox<sup>&reg; </sup></strong><strong>with food and drink </strong></p><p>Take this medicine with meals. This is because it helps this medicine to be absorbed into the body.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>&bull; Are you pregnant, or do you think you might be pregnant? Although this medicine is not known to harm the unborn child, it will only be given to a pregnant woman if it is really necessary.</p><p>&bull; Are you breast-feeding? This medicine should not be given to women who are breastfeeding. This is because small amounts of it enter the milk.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines </strong></p><p>You may get dizzy when taking this medicine. This may affect your ability to drive or operate machinery. If this happens, do not drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>The dispensing label will tell you how much of this medicine you should take and how often you should take. Please read it carefully. The dose your doctor prescribes depends on the type of infection and how bad the infection is. It also depends on how well the kidneys are working. Your doctor will explain this to you.</p><p>Information on how many tablets and how often they should be taken will exactly be written on the dispensing label. Please read it carefully.</p><p>The tablets should be taken with meals because this improves the absorption of cefpodoxime into the body.</p><p>The recommended doses are given below. However, your doctor may prescribe a different dose to those below: if this applies to you, discuss it with your doctor if you have not already done so. The dose you are prescribed will depend on the type and severity of the infection.</p><p><strong>The usual dose is: </strong></p><p><strong>Adults and Elderly with no kidney problems: </strong></p><p>Sinus infections: 200 mg twice a day.</p><p>Throat infections: 100 mg twice a day.</p><p>Chest infections: 200 mg twice a day.</p><p><strong>Children: </strong></p><p>Cefpodoxime proxetil Powder for Oral Suspension is available to treat infants over the age of two weeks and children.</p><p><strong>Adults with kidney problems: </strong></p><p>Depending on how serious the kidney problems are, the usual dose of cefpodoxime for the type of infection you have may need to be given only once a day instead of twice a day or even once every two days. Your doctor will decide how much you need to take.</p><p>If you are on haemodialysis you will usually be given a dose after each dialysis session. Your doctor will tell you how much to take each time.</p><p><strong>If you take more </strong><strong>Cefodox<sup>&reg; </sup></strong><strong>than you should </strong></p><p>If you have taken more of this medicine than you should, talk to your doctor straight away or go to the nearest hospital accident and emergency department. Take the medicine with you in the carton, so that staff will know exactly what has been taken.</p><p><strong>If you forget to take </strong><strong>Cefodox<sup>&reg;</sup></strong></p><p>If you forget to take a dose of this medicine at the right time, take it as soon as you remember. Do not take a double dose to make up for forgotten doses.</p><p><strong>If you stop taking </strong><strong>Cefodox<sup>&reg;</sup></strong></p><p>It is important that you take this medicine until you finish the prescribed course. You should not stop the medicine just because you feel better. If you stop too soon, the infection may start up again. If the person being treated still feels unwell at the end of the prescribed course of treatment, or feels worse during treatment, tell your doctor.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Severe allergic reactions to this medicine are very rare (affects less than 1 in 10 000 people). These can include: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden wheeziness and tightness of chest.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of eyelids, face or lips.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin rashes that can blister and may involve the eyes, mouth and throat and genitals.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of consciousness (fainting).</p><p>&nbsp;</p><p>All of these allergic reactions need urgent medical attention. If you think you are having any of these types of reaction, stop taking this medicine and contact your doctor or your nearest hospital accident and emergency department.</p><p><strong>Common side effects (affect less than 1 in 10 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach problems: bloating, nausea, vomiting, stomach pain, flatulence (wind) and diarrhea. If you have severe diarrhea or if you see blood in your diarrhea you should stop taking this medicine and talk to your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eating problems: loss of appetite.</p><p><strong>Uncommon side effects (affect less than 1 in 100 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immune system problems: hypersensitivity reactions (These are skin rashes that are less severe allergic reactions that mentioned above, lumpy rash (hives), itching).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nervous system disorders: headaches, pins and needles, dizziness.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ear problems: ringing in the ears.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General problems: feeling or being sick, weakness and a feeling of generally being unwell.</p><p><strong>Rare side effects (affect less than 1 in 1000 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver and bile problems: changes in blood tests that check how your liver is working.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood problems: anaemia, drops in the numbers of different cells in the blood (symptoms can include tiredness, new infections and easy bruising or bleeding), increases in some types of white blood cells, increases in the numbers of small cells that are needed for clotting of the blood.</p><p><strong>Very rare side effects (affect less than 1 in 10000 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immune system problems: anaphylactic reactions (e.g. bronchospasms, purpura and edema of the face and extremities).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney problems: changes in kidney function.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver and bile problems: liver damage causing jaundice (this may show as a yellowing of the skin or whites of the eyes).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections: Having a course of cefpodoxime can temporarily increase the chance that you can get infections caused by other sorts of germs. For example, thrush may occur.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood and the lymphatic system problems: a type of anaemia that can be severe and is caused by red blood cells breaking up. If you are having a blood test for any reason, tell the person who is taking your blood sample that you are taking this medicine as it may affect your result.</p><p><strong>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Cefodox<sup>&reg;</sup> </strong>tablets after the expiry date (EXP) which is stated on the blister and the carton.</p><p>The expiry date refers to the last day of that month.</p><p><strong>Cefodox<sup>&reg;</sup> </strong>tablets: Store below 30&deg;C.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Cefpodoxime Proxetil.</p><p>The other ingredients are microcrystalline cellulose, silicon dioxide, croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, opadry, yellow iron oxide, PEG.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cefodox® 100 mg tablets: creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF1 on the other, packed in Alu/Alu blisters, intended for oral use.
Pack size: 10 Film Coated Tablets.

Cefodox® 200 mg tablets: creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF2 on the other, packed in Alu/Alu blisters, intended for oral use.
Pack size: 14 Film Coated Tablets.
20 Film Coated Tablets.


To report any side effect(s):
•Saudi Arabia:
The National Pharmacovigilance Center (NPC):
SFDA Call Center: 19999 
E-mail: npc.drug@sfda.gov.sa 
Website: https://ade.sfda.gov.sa
•United Arab of Emirates:
Pharmacovigilance and Medical Device Section
P.O. Box: 1853, Tel: 80011111
Email: pv@mohap.gov.ae
Drug Department, Ministry of Health & Prevention
Dubai-UAE.
•Other GCC States:
Please contact the relevant competent authority.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharma International Company</p><p>Amman - Jordan</p><p>Tel: 00962-6-5158890 / 5157893</p><p>Fax: 00962-6-5154753</p><p>Email: marketing@pic-jo.com</p><p>&nbsp;</p><p>This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 08/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>سيفودوكس<sup>&reg;</sup></strong> هو مضاد حيوي. ينتمي إلى مجموعة من المضادات الحيوية التي تعرف &nbsp;بالسيفالوسبورينات. تشبه هذه الأنواع من المضادات الحيوية البنسيلين.</p><p dir="RTL">يقضي <strong>سيفودوكس<sup>&reg; </sup></strong>على<strong><sup> </sup></strong>البكتيريا و يمكن استعماله ضد أنواع مختلفة من الالتهابات.</p><p dir="RTL">مثل جميع المضادات الحيوية، يعد <strong>سيفودوكس<sup>&reg; </sup></strong>فعال فقط ضد بعض أنواع البكتيريا. لذلك فهو مناسب فقط لعلاج بعض أنواع الالتهابات.</p><p dir="RTL">يمكن استعمال <strong>سيفودوكس<sup>&reg; </sup></strong>لعلاج ما يلي:</p><p dir="RTL">&bull; التهابات الجيوب الأنفية.</p><p dir="RTL">&bull; التهابات الحلق.</p><p dir="RTL">&bull; التهابات الصدر مثل التهاب القصبات الهوائية وبعض أنواع الالتهاب الرئوي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم تناول</strong> <strong>سيفودوكس<sup>&reg;</sup></strong><strong> </strong><strong>في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تحسس (فرط التحسس) لسيفبودوكسيم بروكسيتيل أو لأي مكونات أخرى في <strong>سيفودوكس<sup>&reg;</sup></strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تحسس (فرط التحسس) لأي مضاد حيوي آخر ينتمي إلى مجموعة السيفالوسبورينات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا عانيت سابقا من تفاعل تحسسي حاد لأي مضاد حيوي ينتمي إلى مجموعة البنسيلين.</p><p dir="RTL">ليس كل الأشخاص الذين يعانون من تحسس للبنسيلين لديهم أيضا تحسس للسيفالوسبورينات.</p><p dir="RTL">مع ذلك، يجب عدم تناول هذا الدواء إذا عانيت سابقا من تفاعل تحسسي حاد لأي من البنسيلينات. وذلك لأنه قد يكون لديك أيضا تحسس لهذا الدواء.</p><p dir="RTL">إذا لم تكن متاكدا من أي شيء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>الاحتياطات الخاصة مع </strong><strong>سيفودوكس<sup>&reg;</sup>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا عانيت سابقا من تفاعلات تحسسية لأي من المضادات الحيوية، أخبر طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا تم إخبارك سابقا من قبل الطبيب بأنك تعاني من قصور في وظيفة الكلى. أيضا، إذا كنت تخضع لأي نوع من العلاج (مثل، الديلزة) لعلاج قصور وظائف الكلى. من الممكن تناول <strong>سيفودوكس<sup>&reg;</sup></strong><strong> </strong>ولكن قد تحتاج لجرعة أقل.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا عانيت سابقا من التهاب في الأمعاء، أو أي مرض حاد آخر يؤثر على القناة الهضمية.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>قد يغير هذا الدواء من نتيجة بعض فحوصات الدم (مثل، اختبار مطابقة الدم و اختبار كومبس). من المهم أن تخبر طبيبك بأنك تتناول هذا الدواء إذا كان عليك القيام بأي من هذه الفحوصات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يغير هذا الدواء أيضا من نتائج فحوصات البول للكشف عن السكر (مثل، فحص بنديكت أو فيهلينج). إذا كنت تعاني من داء السكري و تقوم بفحص البول بشكل دوري، أخبر طبيبك. وذلك لأنه قد يكون من الضروري القيام بفحوصات أخرى لمراقبة داء السكري خلال فترة تناول هذا الدواء.</p><p dir="RTL"><strong>تناول أدوية أخرى</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها بدون وصفة طبية.</p><p dir="RTL">قد يتأثر هذا الدواء بالأدوية الأخرى التي يتم إخراجها عن طريق الكلى. بشكل خاص إذا كانت هذه الأدوية الأخرى تؤثر أيضا على كيفية عمل الكلى. هناك العديد من الأدوية التي يمكن أن تقوم بذلك، لذلك يجب عليك التأكد من طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL"><strong>بشكل خاص، أخبر طبيبك أو الصيدلي إذا كنت تتناول أي مما يلي:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية التي تعرف بالأمينوجليكوسايد (مثل، جينتاميسين).</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>أقراص الماء أو الحقن (مدرات البول) مثل، فيوروسيميد. قد يكون من الضروري أن تتأكد من صحة عمل الكلى بشكل دوري خلال فترة العلاج. يمكن القيام بذلك عن طريق فحوصات الدم والبول.</p><p dir="RTL">لا تتناول <strong>سيفودوكس<sup>&reg; </sup></strong>في نفس وقت تناول الأدوية التي تعمل كمضاد لحموضة المعدة، تتضمن هذه:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الحموضة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية مثل رانيتيدين، فاموتيدين أو سيميتيدين (تعرف بمضادات مستقبلات الهستامين-2).</p><p dir="RTL">اترك 2 أو 3 ساعات بعد تناول هذا الدواء و قبل تناول أي من هذه الأدوية الأخرى.</p><p dir="RTL"><strong>تناول </strong><strong>سيفودوكس<sup>&reg; </sup>مع الطعام<sup> </sup></strong><strong>و الشراب</strong></p><p dir="RTL">تناول هذا الدواء مع تناول الطعام. و لأن ذلك يساعد في امتصاص هذا الدواء إلى الجسم.</p><p dir="RTL"><strong>الحمل و الرضاعة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل أنت حامل، أو تعتقدين بأنك حامل؟ على الرغم من أنه من غير المعروف إذا كان هذا الدواء يؤذي الجنين، سيتم إعطاؤه للمرأة الحامل فقط إذا كان ضروريا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل أنت مرضعة؟ يجب عدم إعطاء هذا الدواء للمرضعات. و ذلك لأن كمية قليلة من هذا الدواء تفرز في حليب الثدي.</p><p dir="RTL">استشيري طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تشعر بالدوار عند تناول هذا الدواء. قد يؤثر هذا على قدرتك على القيادة أو تشغيل الآلات. إذا حدث هذا، تجنب القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول هذا الدواء تماما كما أخبرك طبيبك أو الصيدلي. يجب التأكد من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL">سوف يخبرك ملصق الصيدلي عن الجرعة التي يجب تناولها و تكرار تناولها. قم بقراءته بحذر. تعتمد الجرعة التي يصفها الطبيب على نوع الالتهاب و مدى سوء هذا الالتهاب. و تعتمد أيضا على صحة عمل الكلى. سيفسر لك الطبيب ذلك.</p><p dir="RTL">ستتم كتابة المعلومات حول عدد الأقراص و عدد مرات تناولها على ملصق الصيدلي. قم بقراءته بحذر.</p><p dir="RTL">يجب تناول الأقراص مع تناول الطعام لأن ذلك سوف يحسن من امتصاص سيفبودوكسيم إلى الجسم.</p><p dir="RTL">الجرعة الموصى بها مذكورة في الأسفل. مع ذلك، قد يصف طبيبك جرعة مختلفة عن الجرعات المذكورة في الأسفل: إذا انطبق هذا عليك، ناقش ذلك مع طبيبك إذا لم تقم بذلك مسبقا. ستعتمد الجرعة التي سيتم وصفها على نوع و حدة الالتهاب.</p><p dir="RTL"><strong>الجرعة المعتادة هي:</strong></p><p dir="RTL"><strong>البالغون و كبار السن الذين لا يعانون من مشاكل في الكلى:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الجيوب الأنفية: 200 ملغم مرتين في اليوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الحلق: 100 ملغم مرتين في اليوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الصدر: 200 ملغم مرتين في اليوم.</p><p dir="RTL"><strong>الأطفال:</strong></p><p dir="RTL">يتوفر مسحوق سيفبودوكسيم بروكسيتيل لتحضير معلق عن طريق الفم لعلاج الرضع الذين تزيد أعمارهم عن أسبوعين و الأطفال.</p><p dir="RTL"><strong>البالغون الذين يعانون من مشاكل في الكلى:</strong></p><p dir="RTL">اعتمادا على مدى خطورة مشاكل الكلى، قد تحتاج لتناول الجرعة المعتادة من سيفبودوكسيم<strong><sup> </sup></strong>مرة واحدة فقط في اليوم بدلاً من مرتين في اليوم أو حتى مرة واحدة كل يومين لعلاج الالتهاب الذي تعاني منه. سيقرر طبيبك الجرعة التي تحتاج إلى تناولها.</p><p dir="RTL">إذا كنت تخضع للديلزة الدموية سيتم إعطاؤك عادة جرعة بعد كل جلسة ديلزة.</p><p dir="RTL">سيخبرك طبيبك عن الجرعة التي يجب تناولها في كل مرة.</p><p dir="RTL"><strong>إذا تناولت </strong><strong>سيفودوكس<sup>&reg;</sup></strong><strong> </strong><strong>أكثر مما يجب</strong></p><p dir="RTL">إذا تناولت من هذا الدواء أكثر مما يجب، تحدث مع طبيبك فورا أو اذهب إلى قسم الحوادث والطوارئ في أقرب المستشفى. اصطحب الدواء معك في العلبة، ليعرف الطاقم ماذا تناولت بالضبط.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>نسيت تناول جرعة </strong><strong>سيفودوكس<sup>&reg;</sup></strong></p><p dir="RTL">إذا نسيت تناول جرعة من هذا الدواء في الوقت المناسب، تناولها فور تذكرك. لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها.</p><p dir="RTL"><strong>إذا توقفت عن تناول</strong> <strong>سيفودوكس<sup>&reg;</sup></strong></p><p dir="RTL">من المهم أن تتناول هذا الدواء إلى أن تنهي مدة العلاج الموصوفة. يجب أن لا تتوقف عن تناول هذا الدواء فقط لأنك تشعر بتحسن. إذا توقفت عن تناول الدواء في وقت مبكر جدا، قد تصاب بالالتهاب مجددا. إذا كان الشخص الذي يخضع للعلاج لا يزال يشعر بأنه ليس على ما يرام في نهاية مدة العلاج الموصوفة، أو يشعر بأن حالته تزداد سوءا خلال العلاج، أخبر طبيبك بذلك.</p><p dir="RTL">إذا كان لديك أي اسئلة إضافية عن استعمال هذا المستحضر، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثار جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL"><strong>التفاعلات التحسسية الحادة لهذا الدواء نادرة جدا (تؤثر على أقل من 1 من كل 10000 شخص). قد تتضمن هذه:</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>أزيز تنفسي مفاجيء و ضيق في الصدر.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تورم جفون العينين، الوجه أو الشفاه.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>طفح جلدي حاد يمكن أن يتنفط و قد يشمل العينين، الفم و الحلق و الأعضاء التناسلية.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>فقدان الوعي (إغماء).</p><p dir="RTL">جميع هذه التفاعلات التحسسية تحتاج إلى رعاية طبية طارئة. إذا كنت تعتقد بأنك تعاني من أي من أنواع التفاعلات هذه، توقف عن تناول هذا الدواء و اتصل مع طبيبك أو قسم الحوادث و الطوارئ في أقرب المستشفى.</p><p dir="RTL"><strong>آثار جانبية شائعة (تؤثر على أقل من 1 من كل 10 أشخاص):</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>مشاكل في المعدة: انتفاخ، الشعور بالغثيان، قيء، ألم في المعدة، انتفاخ البطن (غازات) و إسهال. إذا كنت تعاني من إسهال حاد أو في حال ظهور دم في الإسهال يجب عليك التوقف عن تناول هذا الدواء و تحدث مع طبيبك فورا.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>اضطرابات الأكل: فقدان الشهية.</p><p dir="RTL"><strong>آثار جانبية غير شائعة (تؤثر على أقل من 1 من كل 100 شخص):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في جهاز المناعة: تفاعلات فرط التحسس (تشمل طفح جلدي الذي يكون أقل حدة من التفاعلات التحسسية التي تم ذكرها في الأعلى، طفح جلدي يرافقه ظهور نتوءات على الجلد (شرى)، حكة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الجهاز العصبي: صداع، الشعور بوخز خفيف، الشعور بالدوار.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الأذنين: رنين في الأذنين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل عامة: الشعور بالغثيان أو قيء، الشعور بالضعف و الشعور العام بأنك لست على ما يرام.</p><p dir="RTL"><strong>آثار جانبية نادرة (تؤثر على أقل من 1 من كل 1000 شخص):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكبد و الصفراء: تغيرات في فحوصات الدم التي تتحقق من صحة عمل الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الدم: فقر الدم، انخفاض في أعداد خلايا الدم المختلفة (قد تتضمن الأعراض الشعور بالتعب، التهابات جديدة و سهولة التعرض للكدمات أو النزيف)، زيادة في بعض أنواع خلايا الدم البيضاء، زيادة في عدد الخلايا الصغيرة اللازمة لتخثر الدم.</p><p dir="RTL"><strong>آثار جانبية نادرة جدا (تؤثر على أقل من 1 من كل 10000 شخص):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في جهاز المناعة: تفاعلات فرط التحسس (مثل تشنج القصبات الهوائية، البرفرية و وذمة في الوجه والأطراف).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكلى: تغيرات في وظائف الكلى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكبد و الصفراء: تلف &nbsp;في الكبد يسبب اليرقان (يظهر هذا عل شكل اصفرار في الجلد أو المنطقة البيضاء في العيون).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهابات: إن الخضوع للعلاج باستعمال سيفبودوكسيم يزيد من فرصة التعرض للالتهابات التي قد تسببها أنواع أخرى من الجراثيم بشكل مؤقت. على سبيل المثال، قد تصاب بالقلاع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الدم و الجهاز الليمفاوي: نوع من فقر الدم الذي يمكن أن يكون حادا و ناتج عن تكسر خلايا الدم الحمراء. إذا كنت ستقوم بفحص دم لأي سبب، أخبر الشخص الذي يقوم بسحب عينة الدم بأنك تتناول هذا الدواء لأنه قد يؤثر على نتيجة الفحص.</p><p dir="RTL"><strong>إذا عانيت من أي آثار جانبية، تحدث مع طبيبك، الصيدلي أو الممرض. هذا يتضمن أي آثار جانبية غير مذكورة في هذه النشرة.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول الأطفال و نظرهم.</p><p dir="RTL">لا تستعمل أقراص <strong>سيفودوكس<sup>&reg; </sup></strong>بعد تاريخ انتهاء الصلاحية المذكورعلى الشريط و العلبة الخارجية.</p><p dir="RTL">تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL"><strong>سيفودوكس<sup>&reg;</sup></strong> أقراص: يحفظ في درجة حرارة دون 30&deg;م.</p><p dir="RTL">يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي سيفبودوكسيم بروكسيتيل.</p><p>المكونات الأخرى هي ميكروكريستالين سيليلوز، ثاني أكسيد السيليكون، كروسكارميلوز الصوديوم، &nbsp;جلايكولات نشا الصوديوم، لوريل سلفات الصوديوم، ثاني أكسيد السيليكون الغروي، ستيرات المغنيسيوم، أوبادري، أكسيد الحديد الأصفر، بولي إيثيلين جلايكول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أقراص </strong><strong>سيفودوكس<sup>&reg;</sup></strong><strong> </strong><strong>100 ملغم</strong><strong>:</strong><strong> </strong>أقراص مغلفة كريمية اللون مائلة إلى اللون الأصفر، بيضاوية الشكل، محدبة، محفور على أحد الأوجه PhI وعلى الوجه الآخر خط التقسيم &nbsp;و CF1، معبأة في أشرطة ألومنيوم/ألومنيوم، معدة للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم العبوة:</strong> 10 أقراص مغلفة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أقراص </strong><strong>سيفودوكس<sup>&reg;</sup></strong><strong> </strong><strong>200 </strong><strong>ملغم:</strong><strong> </strong>أقراص مغلفة كريمية اللون مائلة إلى اللون الأصفر، بيضاوية الشكل، محدبة، محفور على أحد الأوجه PhI وعلى الوجه الآخر خط التقسيم &nbsp;و CF2، معبأة في أشرطة ألومنيوم/ألومنيوم، معدة للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم العبوة:</strong> 14 أقراص مغلفة.</p><p dir="RTL">20 قرص مغلف.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong>:</strong></p><p dir="RTL"><strong>المملكة</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>السعودية</strong><strong>:</strong></p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الالكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>&bull;</strong><strong>الإمارات</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>المتحدة</strong><strong>:</strong></p><p dir="RTL">قسم اليقظة الدوائية والأجهزة الطبية</p><p dir="RTL">ص.ب: 1853، هاتف: 80011111</p><p dir="RTL">البريد الإلكتروني: pv@mohap.gov.ae</p><p dir="RTL">قسم الأدوية، وزارة الصحة و وقاية المجتمع</p><p dir="RTL">دبي- الإمارات العربية المتحدة.</p><p dir="RTL"><strong>&bull;</strong><strong> دول</strong><strong> </strong><strong>الخليج العربي الأخرى</strong><strong>:</strong></p><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><br />الشركة الدولية للدواء<br />عمان - الأردن<br />الهاتف: 5157893/5158890-6-00962&nbsp;<br />فاكس: 5154753-6-00962<br />marketing@pic-jo.comالبريد الإلكتروني:</p><p><strong>&nbsp;</strong></p><p dir="RTL">هذه النشرة لا تحتوي على جميع المعلومات عن المستحضر. إذا كان لديك أية أسئلة أو لم تكن متأكدا من أي شيء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 08/2022 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefodox® 100mg Film Coated Tablets.
Cefodox® 200mg Film Coated Tablets.
Cefpodoxime (proxetil) 100mg Film Coated Tablets.
Cefpodoxime (proxetil) 200mg Film Coated Tablets.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefodox® 100mg: Each film coated tablets contains 100mg cefpodoxime (proxetil).
Cefodox® 200mg: Each film coated tablets contains 200mg cefpodoxime (proxetil).

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets.
Cefodox® 100 mg tablets: creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF1 on the other, packed in Alu/Alu blisters, intended for oral use.
Cefodox® 200 mg tablets: creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF2 on the other, packed in Alu/Alu blisters, intended for oral use.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefpodoxime proxetil is indicated for the treatment of the following infections when caused by susceptible organisms.</p><p>- Sinusitis.</p><p>- Tonsillitis and pharyngitis.</p><p>In the above indications, cefpodoxime should be reserved for recurrent or chronic infections, or for infections where the causative organism is known or suspected to be resistant to commonly used antibiotics <em>or in case the commonly used antibiotic</em> <em>cannot be used for any reason</em>.</p><p>- Acute bronchitis.</p><p>- Exacerbation of chronic bronchitis.</p><p>- Bacterial pneumonia.</p><p>Cefpodoxime is not the preferred antibiotic for the treatment of staphylococcal pneumonia and should not be used in the treatment of atypical pneumonia caused by organisms such as Legionella, Mycoplasma and Chlamydia <em>(see also section 5.1)</em>.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><u>Adults and adolescents with normal renal function:</u></p><p>Sinusitis: 200mg twice daily.</p><p>Tonsillitis and pharyngitis: 100mg twice daily.</p><p>Acute bronchitis, exacerbation of chronic bronchitis and bacterial pneumonia: 100-200 mg twice daily, dependent on the severity of the infection.</p><p><u>Elderly:</u></p><p>It is not necessary to modify the dose in elderly patients with normal renal function.</p><p><u>Children:</u></p><p>Cefpodoxime proxetil Powder for oral Suspension is available to treat infants (over 15 days old) and children. Please refer to the separate Summary of Product Characteristics for details.</p><p><u>Renal Impairment:</u></p><p>The dose of cefpodoxime does not require modification if creatinine clearance exceeds 40ml/min. Below this value, pharmacokinetic studies indicate an increase in plasma elimination half-life. Therefore, the dose should be adjusted appropriately.</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>CREATININE CLEARANCE</strong></p><p>(ML/MIN)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>39 &ndash; 10</p></td><td style="vertical-align:top"><p>Unit dose<sup>1</sup> administered as a single dose every 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 10</p></td><td style="vertical-align:top"><p>Unit dose<sup>1</sup> administered as a single dose every 48 hours.</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis Patients</p></td><td style="vertical-align:top"><p>Unit dose<sup>1</sup> administered after each dialysis session.</p></td></tr></tbody></table><p><u>NOTE</u>:<sup> 1</sup>The unit dose is either 100mg or 200mg, depending on the type of infection as stated above.</p><p><u>Hepatic Impairment:</u></p><p>The dose does not require modification in cases of hepatic impairment.</p><p><u>Duration</u></p><p>The duration of therapy depends on the patient, the indication and the causative pathogen(s).</p><p><strong><em>Method of Administration</em></strong></p><p>For oral administration.</p><p>The tablets should be taken with food for optimum absorption.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to any of the cephalosporins or to any of the excipients of the tablet listed in section 6.1.
Previous immediate and/or severe hypersensitivity reaction to a penicillin or to any other type of beta-lactam drug.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Hypersensitivity reactions</u></em></p><p>Before therapy with cefpodoxime is instituted, careful inquiry should be made to determine whether the patient has had any previous hypersensitivity reactions to cefpodoxime, cephalosporins, penicillins, or other beta-lactam drugs.</p><p>Cefpodoxime is contraindicated in patients who have had a previous hypersensitivity reaction to any cephalosporin.</p><p>It is also contraindicated in patients who have had a previous immediate and /or any severe hypersensitivity reaction to any penicillin or to any other beta-lactam drug.</p><p>Cefpodoxime should be given with caution to patients who have had any other type of hypersensitivity reaction to a penicillin or any other beta-lactam drug.</p><p>Hypersensitivity reactions (anaphylaxis) observed with beta-lactam antibiotics can be serious and occasionally fatal. The onset of any manifestation of hypersensitivity indicates that treatment should be stopped.</p><p><em><u>Renal Insufficiency</u></em></p><p>In cases of severe renal insufficiency it may be necessary to reduce the dose dependent on the creatinine clearance (see section 4.2).</p><p><em><u>Gastrointestinal disease</u></em></p><p>Cefpodoxime should always be used with caution in patients with a history of gastrointestinal disease, particularly colitis. Antibiotic associated diarrhoea, colitis and pseudomembranous colitis have been reported with the use of cefpodoxime.</p><p>These diagnoses should be considered in any patient who develops diarrhea during or shortly after treatment. Cefpodoxime should be discontinued if severe and/or bloody diarrhea occurs during treatment and appropriate therapy instituted.</p><p><em><u>Blood monitoring</u></em></p><p>As with all beta-lactam antibiotics, neutropenia and more rarely agranulocytosis may develop particularly during extended treatment. For cases of treatment lasting longer than 10 days, the blood count should be monitored and treatment discontinued if neutropenia is found.</p><p>Cephalosporins may be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug. This can produce a positive Coomb&#39;s test and very rarely, haemolytic anaemia. Cross-reactivity may occur with penicillin for this reaction.</p><p><em><u>Renal function</u></em></p><p>Changes in renal function have been observed with cephalosporin antibiotics, particularly when given concurrently with potentially nephrotoxic drugs such as aminoglycosides and/or potential diuretics. In such cases, renal function should be monitored.</p><p><em><u>Prolonged use</u></em></p><p>As with other antibiotics, the prolonged use of cefpodoxime proxetil may result in the overgrowth of non-susceptible organisms. With oral antibiotics the normal colonic flora may be altered, allowing overgrowth by clostridia with consequent pseudomembranous colitis. Repeated evaluation of the patient is essential and if superinfection occurs during therapy, appropriate measures should be taken.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically significant drug interactions have been reported during the course of clinical studies.</p><p>Histamine H2-antagonists and antacids reduce the bioavailibility of cefpodoxime. Probenecid reduces the excretion of cephalosporins. Cephlasporins potentially enhance the anticoagulant effect of coumarins and reduce the contraceptive effect of oestrogens.</p><p><em><u>Antacids and H2 blockers</u></em></p><p>Studies have shown that bioavailability is decreased by approximately 30% when cefpodoxime is administered with drugs which neutralise gastric pH or inhibit acid secretions. Therefore, such drugs as antacids of the mineral type and H2 blockers such as ranitidine, which can cause an increase in gastric pH, should be taken 2 to 3 hours after cefpodoxime administration.</p><p><em><u>Influence on laboratory diagnostic tests</u></em></p><p>A false positive reaction for glucose in the urine may occur with Benedict&#39;s or Fehling&#39;s solution or with copper sulphate test tablets, but not with tests based on enzymatic glucose oxidase reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For cefpodoxime proxetil no clinical data on exposed pregnancies are available.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).</p><p>Caution should be exercised when prescribing to pregnant women.</p><p>Studies carried out in several animal species have not shown any teratogenic or fetotoxic effects. However, the safety of cefpodoxime proxetil in pregnancy has not been established and, as with all drugs, it should be administered with caution during the early months of pregnancy.</p><p>Cefpodoxime is excreted in human milk. Mothers should stop breastfeeding during treatment with cefpodoxime.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefpodoxime proxetil has minor or moderate influence on the ability to drive and use machines.</p><p>Dizziness has been reported during treatment with cefpodoxime and may affect patients&rsquo; ability to drive or operate machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In this section undesirable effects are defined as follows:</p><p>Very common (&ge; 1/10)</p><p>Common (&gt; 1/100 to &lt; 1/10)</p><p>Uncommon (&ge; 1/1,000 to &lt; 1/100)</p><p>Rare (&ge; 1/10,000 to &lt; 1/1,000)</p><p>Very rare (&lt; 1/10,000)</p><p>Not known (cannot be estimated from the available data)</p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ</strong></p><p><strong>Class</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p><p><strong>(</strong>&ge;<strong>1/100</strong></p><p><strong>To &lt; 1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p><p><strong>(</strong>&ge;<strong>1/1,000 to &lt;1/100)</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p><strong>(</strong>&ge;<strong>1/10,000 to &lt;1/1,000)</strong></p></td><td style="vertical-align:top"><p><strong>Very rare</strong></p><p><strong>(&lt; 1/10,000)</strong></p><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Not known</strong></p><p><strong>(cannot be</strong></p><p><strong>estimated from</strong></p><p><strong>the available</strong></p><p><strong>data)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections and</strong></p><p><strong>Infestations</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>There can be</p><p>multiplication of</p><p>non-sensitive</p><p>microorganisms</p><p>(see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p><strong>Blood and</strong></p><p><strong>lymphatic</strong></p><p><strong>system</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Haematologica</p><p>l disorders,</p><p>such as</p><p>reduction in</p><p>haemoglobin,</p><p>thrombocytosis, thrombocytopenia, leucopenia</p><p>and eosinophilia.</p></td><td style="vertical-align:top"><p>Haemolytic</p><p>anaemia.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune</strong></p><p><strong>system</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Hypersensitivity reactions of all degrees of severity have been observed (see section 4.3 and 4.4).</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Allergic</p><p>reactions, such</p><p>as</p><p>mucocutaneou</p><p>s reactions,</p><p>skin rashes,</p><p>urticaria and</p><p>pruritus.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dermal</p><p>reactions</p><p>with</p><p>blistering</p><p>(erythema</p><p>multiforme,</p><p>Stevens-</p><p>Johnson</p><p>syndrome,</p><p>Lyell</p><p>syndrome).</p><p>The</p><p>Medication should be terminated if</p><p>such</p><p>symptoms</p><p>occur. As</p><p>with other</p><p>cephalosporins, there have been very rare reports</p><p>of anaphylactic</p><p>reactions,</p><p>bronchospas</p><p>m, purpura</p><p>and angioedema.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism</strong></p><p><strong>and nutrition</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>Loss of</p><p>appetite.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous</strong></p><p><strong>system</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Headaches,</p><p>paraesthesiae,</p><p>dizziness.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Ear and</strong></p><p><strong>labyrinth</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Tinnitus.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Gastric</p><p>pressure, nausea,</p><p>vomiting, abdominal</p><p>pain,</p><p>flatulence,</p><p>diarrhea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bloody</p><p>diarrhea can</p><p>occur as a</p><p>symptom of</p><p>enterocolitis.</p><p>The possibility</p><p>of</p><p>pseudomembra</p><p>nous</p><p>enterocolitis</p><p>should be</p><p>considered if</p><p>severe or</p><p>persistent</p><p>diarrhea occurs during</p><p>or after</p><p>treatment (see</p><p>section 4.4).</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Transient</p><p>moderate</p><p>elevations of</p><p>ASAT, ALAT</p><p>and alkaline</p><p>phosphatase</p><p>and/or</p><p>bilirubin.</p><p>These</p><p>laboratory</p><p>abnormalities</p><p>which may be</p><p>explained by</p><p>the infection,</p><p>may rarely</p><p>exceed twice</p><p>the upper limit</p><p>of the named</p><p>range and elicit</p><p>a pattern of</p><p>liver injury,</p><p>usually</p><p>cholestatic and</p><p>most often</p><p>asymptomatic.</p></td><td style="vertical-align:top"><p>Liver damage.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and</strong></p><p><strong>Urinary disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Slight</p><p>increases in</p><p>blood urea</p><p>and</p><p>creatinine.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>General</strong></p><p><strong>disorders and</strong></p><p><strong>administration site</strong></p><p><strong>conditions</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Asthenia or</p><p>malaise.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&bull;Saudi Arabia:</strong></p><p>The National Pharmacovigilance Center (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>&bull;United Arab of Emirates:</strong></p><p>Pharmacovigilance and Medical Device Section</p><p>P.O. Box: 1853, Tel: 80011111</p><p>Email: pv@mohap.gov.ae</p><p>Drug Department, Ministry of Health &amp; Prevention</p><p>Dubai-UAE.</p><p><strong>&bull;Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of overdose with cefpodoxime proxetil, supportive and symptomatic therapy is indicated.</p><p>In cases of overdose, particularly in patients with renal insufficiency, encephalopathy may occur. The encephalopathy is usually reversible once cefpodoxime plasma levels have fallen.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> &beta;-lactam antibiotic, 3rd generation cephalosporines, ATC code: J01DD 13</p><p><u>Mechanism of action</u></p><p>Like other &beta;-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins. This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.</p><p><u>Mechanisms of Resistance</u></p><p>Bacterial resistance to cefpodoxime may be due to one or more of the following mechanisms:</p><p>&bull; Hydrolysis by beta-lactamases. Cefpodoxime may be efficiently hydrolysed by certain of the extended-spectrum beta-lactamases (ESBLs) and by the chromosomally-encoded (AmpC) enzyme that may be induced or stably derepressed in certain aerobic gram-negative bacterial species.</p><p>&bull; Reduced affinity of penicillin-binding proteins for cefpodoxime.</p><p>&bull; Outer membrane impermeability, which restricts access of cefpodoxime to penicillin binding proteins in gram-negative organisms.</p><p>&bull; Drug efflux pumps.</p><p>Breakpoints:</p><p>According to the NCCLS (National Committee on Clinical Laboratory Standards) the following breakpoints have been defined for cefpodoxime:</p><p>&bull; Enterobacteriaceae and <em>Staphylococcus </em>spp.: &le; 2 &mu;g/ml susceptible, 4 &mu;g/ml intermediate, &ge; 8 &mu;g/ml resistant.</p><p>&bull; <em>Haemophilus </em>spp.: &le; 2 &mu;g/ml susceptible.</p><p>&bull; <em>Neisseria gonorrhoeae </em>: &le; 0.5 &mu;g/ml susceptible.</p><p>&bull; <em>Streptococcus pneumoniae</em>: &le; 0.5 &mu;g/ml susceptible, 1 &mu;g/ml intermediate, &ge; 2 &mu;g/ml resistant.</p><p>&bull; Other Streptococci that are susceptible to penicillin (MIC90 &le; 0.12 &mu;g/ml) can be considered susceptible to cefpodoxime.</p><p><u>Susceptibility</u></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p><strong>Commonly susceptible species</strong></p><p>Aerobes, Gram positive:</p><p><em>Staphylococcus aureus </em>(methicillin susceptible)</p><p>Coagulase-negative staphylococci (methicillin-susceptible)</p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae</em></p><p><em>Streptococcus pyogenes</em></p><p>Aerobes, Gram negative:</p><p><em>Escherichia coli</em></p><p><em>Haemophilus influenzae</em></p><p>Klebsiella species</p><p><em>Moraxella catarrhalis</em></p><p><em>Neisseria gonorrhoeae</em></p><p><em>Proteus mirabilis</em></p><p><em>Proteus rettgeri</em></p><p>Anaerobes:</p><p>Peptococcus species</p><p>Peptostreptococcus species</p><p><strong>Species for which resistance may be a problem</strong></p><p>Acinetobacter species</p><p>Citrobacter species</p><p>Enterobacter species</p><p><em>Morganella morganii.</em></p><p><strong>Resistant</strong></p><p><em>Bacteroides fragilis</em></p><p><em>Clostridium difficile</em></p><p>Enterococci</p><p><em>Listeria monocytogenes</em></p><p><em>Proteus vulgaris</em></p><p>Pseudomonas species</p><p>Serratia species</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefpodoxime proxetil is taken up in the intestine and is hydrolysed to the active metabolite cefpodoxime. When cefpodoxime proxetil is administered orally to fasting subjects as a tablet corresponding to 100 mg of cefpodoxime, 51.1% is absorbed and absorption is increased by food intake. The volume of distribution is 32.3 l and peak levels of cefpodoxime occur 2 to 3 hours after dosing. The maximum plasma concentration is 1.2 mg/l and 2.5 mg/l after doses of 100 mg and 200 mg respectively.</p><p>Following administration of 100 mg and 200 mg twice daily over 14.5 days, the plasma pharmacokinetic parameters of cefpodoxime remain unchanged.</p><p>Serum protein binding of cefpodoxime, 40% principally to albumin. This binding is non-saturable in type.</p><p>Concentrations of cefpodoxime in excess of the minimum inhibitory levels (MIC) for common pathogens can be achieved in lung parenchyma, bronchial mucosa, pleural fluid, tonsils, interstitial fluid and prostate tissue.</p><p>Studies in healthy volunteers show median concentrations of cefpodoxime in the total ejaculate 6-12 hours following administration of a single 200 mg dose to be above the MIC90 of <em>N. gonorrhoeae.</em></p><p>As the majority of cefpodoxime is eliminated in the urine, the concentration is high.</p><p>(Concentrations in 0-4, 4-8, 8-12 hour fractions after a single dose exceed MIC90 of common urinary pathogens). Good diffusion of cefpodoxime is also seen into renal tissue, with concentrations above MIC<sub>90</sub> of the common urinary pathogens 3-12 hours after an administration of a single 200 mg dose (1.6-3.1 &mu;g/g). Concentrations of cefpodoxime in the medullary and cortical tissues are similar.</p><p>The main route of excretion is renal, 80% is excreted unchanged in the urine with an elimination half-life of approximately 2.4 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Acute Toxicity</strong></p><p>The median lethal dose in mice and rats was above 8 g/kg and 4 g/kg bodyweight, respectively. In Fisher rats doses of 1 g/kg body weight and higher influenced stool consistency and weight gain. Single doses of 800 mg/kg body weight were non-toxic in dogs.</p><p><strong>Repeat-dose toxicity</strong></p><p>Chronic toxicity studies were carried out over 12 months in rats and 6 months in dogs. Maximum daily doses (1000 mg/kg body weight orally in rats and 400 mg/kg orally in dogs) were considerably higher than recommended therapeutic doses (3-8 mg/kg body weight). No mortality was observed in rats receiving 250, 500 or 1000 mg/kg for 12 months. Only at 1000 mg/kg, effects on the GI-tract, softened stools and dilatation of the caecum were observed. Intestinal side effects, which were more pronounced in Fisher rats, are due to the change in intestinal flora caused by the pronounced antibacterial effect of cefpodoxime. Daily administration of 0, 25, 100, and 400 mg/kg body weight to dogs did not reveal mortality. Unchanged cefpodoxime was detected in faeces.</p><p><strong>Reproduction toxicity</strong></p><p>Embryotoxicity studies in rats and rabbits have not revealed any signs of teratogenic potential. Cefpodoxime had no adverse effects on fertility and peri-/postnatal toxicity studies in rats. Cefpodoxime or its metabolites cross the placenta and are excreted in breast milk in rats. No experience is available on the use of cefpodoxime during pregnancy and lactation in humans.</p><p><strong>Mutagenicity</strong></p><p>Extensive mutagenicity testing in different testing models was negative.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, silicon dioxide, croscarmellose sodium, sodium starch glycolate, sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, opadry, yellow iron oxide, PEG.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Cefodox<sup>&reg;</sup> 100 mg tablets:</strong> creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF1 on the other, packed in Alu/Alu blisters, intended for oral use.</p><p><strong>Pack size:</strong> 10 Film Coated Tablets.</p><p>&nbsp;</p><p><strong>Cefodox<sup>&reg;</sup> 200 mg tablets:</strong> creamy-off white, oval, normal convex film coated tablets, engraved with PhI on one face, break lined and CF2 on the other, packed in Alu/Alu blisters, intended for oral use.</p><p><strong>Pack size:</strong> 14 Film Coated Tablets.</p><p>20 Film Coated Tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma Intenational Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893 
Fax: 00962-6-5154753
Email: marketing@pic-jo.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08/2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>